Innocan Pharma Reports First Quarter 2024 Results with Revenue Growth of over 4X to $6.8 Million

/PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on...

Related Keywords

Herzliya ,Tel Aviv ,Israel ,Canada ,Canadian ,Innocan Pharma ,Iris Bincovich ,Roni Kamhi ,Bi Sky Global Ltd ,Company Or Innocan ,Innocan Pharma Corporation ,Prnewswire Innocan Pharma Corporation ,Pharma Corporation ,Pain Management ,Consumer Wellness ,